Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Developmental pluripotency-associated 5 protein (DPPA5) is an RNA-binding protein robustly expressed in undifferentiated pluripotent cells, such as embryonic stem cells (ESCs), embryonic germ cells (EGCs), and primordial germ cells, but is rapidly downregulated upon differentiation[1][3][4]. DPPA5 functions as both a molecular marker of pluripotency and an active regulator of stem cell properties. In human pluripotent stem cells, overexpression of DPPA5 increases the stability and function of the pluripotency factor NANOG via a post-transcriptional mechanism, thereby supporting self-renewal and increasing reprogramming efficiency[1][3]. DPPA5 also suppresses endoplasmic reticulum stress and reduces apoptosis in certain stem cell contexts, further supporting stem cell maintenance and function[1]. It is considered a reliable marker for identifying pluripotent stem cells and for distinguishing undifferentiated cells from those undergoing lineage commitment[3][4]. There is currently no evidence that DPPA5 is a therapeutic target or has approved interacting drugs[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Developmental pluripotency-associated 5 protein (DPPA5).